Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer Of 44 enrolled patients, 39 were evaluable. The primary end point was met ...
The benefit of regional nodal irradiation in the treatment of breast cancer is well established for patients with pathologically positive axillary nodes, but whether it is also beneficial for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback